国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產品名稱 貨號 規格
Recombinant Francisella tularensis subsp. holarctica Protein-export protein secB 1 (secB1) CSB-YP415173FDV
CSB-EP415173FDV
CSB-BP415173FDV
CSB-MP415173FDV
CSB-EP415173FDV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Francisella tularensis subsp. holarctica Na (+)/H (+) antiporter nhaA, partial CSB-YP415174FDV
CSB-EP415174FDV
CSB-BP415174FDV
CSB-MP415174FDV
CSB-EP415174FDV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Francisella tularensis subsp. holarctica UDP-N-acetylmuramate--L-alanine ligase (murC) CSB-YP415175FDV
CSB-EP415175FDV
CSB-BP415175FDV
CSB-MP415175FDV
CSB-EP415175FDV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Francisella tularensis subsp. holarctica Uridylate kinase (pyrH) CSB-YP415176FDV
CSB-EP415176FDV
CSB-BP415176FDV
CSB-MP415176FDV
CSB-EP415176FDV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Francisella tularensis subsp. holarctica 50S ribosomal protein L4 (rplD) CSB-YP415177FDV
CSB-EP415177FDV
CSB-BP415177FDV
CSB-MP415177FDV
CSB-EP415177FDV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Francisella tularensis subsp. holarctica 50S ribosomal protein L14 (rplN) CSB-YP415178FDV
CSB-EP415178FDV
CSB-BP415178FDV
CSB-MP415178FDV
CSB-EP415178FDV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Francisella tularensis subsp. holarctica 50S ribosomal protein L30 (rpmD) CSB-YP415179FDV
CSB-EP415179FDV
CSB-BP415179FDV
CSB-MP415179FDV
CSB-EP415179FDV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Francisella tularensis subsp. holarctica Ribosomal RNA small subunit methyltransferase J (rsmJ) CSB-YP415180FDV
CSB-EP415180FDV
CSB-BP415180FDV
CSB-MP415180FDV
CSB-EP415180FDV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Francisella tularensis subsp. holarctica Chorismate synthase (aroC) CSB-YP415181FDV
CSB-EP415181FDV
CSB-BP415181FDV
CSB-MP415181FDV
CSB-EP415181FDV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Francisella tularensis subsp. holarctica Methionine--tRNA ligase (metG), partial CSB-YP415182FDV
CSB-EP415182FDV
CSB-BP415182FDV
CSB-MP415182FDV
CSB-EP415182FDV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Francisella tularensis subsp. holarctica Cell division topological specificity factor (minE) CSB-YP415183FDV
CSB-EP415183FDV
CSB-BP415183FDV
CSB-MP415183FDV
CSB-EP415183FDV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Francisella tularensis subsp. holarctica tRNA pseudouridine synthase B (truB) CSB-YP415184FDV
CSB-EP415184FDV
CSB-BP415184FDV
CSB-MP415184FDV
CSB-EP415184FDV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Francisella tularensis subsp. holarctica 3-methyl-2-oxobutanoate hydroxymethyltransferase (panB) CSB-YP415185FDV
CSB-EP415185FDV
CSB-BP415185FDV
CSB-MP415185FDV
CSB-EP415185FDV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Francisella tularensis subsp. holarctica tRNA uridine 5-carboxymethylaminomethyl modification enzyme MnmG (mnmG), partial CSB-YP415186FDV
CSB-EP415186FDV
CSB-BP415186FDV
CSB-MP415186FDV
CSB-EP415186FDV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Francisella tularensis subsp. holarctica Glycerol-3-phosphate acyltransferase (plsY), partial CSB-YP415187FDV1
CSB-EP415187FDV1
CSB-BP415187FDV1
CSB-MP415187FDV1
CSB-EP415187FDV1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Francisella tularensis subsp. holarctica ATP-dependent protease ATPase subunit HslU (hslU) CSB-YP415188FDV
CSB-EP415188FDV
CSB-BP415188FDV
CSB-MP415188FDV
CSB-EP415188FDV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Francisella tularensis subsp. holarctica tRNA 2-thiocytidine biosynthesis protein TtcA 2 (ttcA2) CSB-YP415189FDV
CSB-EP415189FDV
CSB-BP415189FDV
CSB-MP415189FDV
CSB-EP415189FDV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Francisella tularensis subsp. holarctica Phosphate acyltransferase (plsX) CSB-YP415190FDV
CSB-EP415190FDV
CSB-BP415190FDV
CSB-MP415190FDV
CSB-EP415190FDV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Francisella tularensis subsp. holarctica Protein grpE (grpE) CSB-YP415191FDV
CSB-EP415191FDV
CSB-BP415191FDV
CSB-MP415191FDV
CSB-EP415191FDV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Francisella tularensis subsp. holarctica UPF0145 protein FTA_1322 (FTA_1322) CSB-YP415192FDV
CSB-EP415192FDV
CSB-BP415192FDV
CSB-MP415192FDV
CSB-EP415192FDV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質形式,可以通過多種方式產生大量蛋白質、修改基因序列和制造有用的商業產品。重組蛋白的技術資源在重組蛋白的開發過程中,除了表達系統之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標簽等。在生產重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質量的重組蛋白,后續的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據他們開發重組蛋白的經驗總結出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產,在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質合成機制來產生由該基因編碼的蛋白質。表達載體可使外源基因在宿主細胞中高效表達,經過多年的發展,表達載體已成為一種成熟而受歡迎的生物技術。在重組蛋白生產過程中是一種基本成分。正如標題所示,本文主要總結了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質?

根據重組蛋白的不同應用,對其生物活性有不同的要求。但是我們如何確保蛋白質的產生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務,您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質有任何疑問,涉及到蛋白質的價格、交貨、質量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>